Results of a national training programme in sentinel lymph node biopsy for breast cancer

British Journal of Surgery

Volumn 100, Issue 5, 2013, Pages 654-661

  Mansel, R E ^a   MacNeill, F ^b   Horgan, K ^e   Goyal, A ^f   Britten, A ^c   Townson, J ^a   Clarke, D ^g   Newcombe, R G ^a   Keshtgar, M ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

^f ROYAL DERBY HOSPITAL   (United Kingdom)

^g WARWICK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874662311     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9058     Document Type: Article

References (21)

1. Johnson JM, Orr RK, Moline SR,. Institutional learning curve for sentinel node biopsy at a community teaching hospital. Am Surg 2001; 67: 1030-1033.
2. Clarke D, Newcombe RG, Mansel RE,; ALMANAC Trialists Group. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004; 11 (Suppl): 211S-215S.
3. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al,. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609.
4. Keshtgar MR, Chicken DW, Waddington WA, Raven W, Ell PJ,. A training simulator for sentinel node biopsy in breast cancer: a new standard. Eur J Surg Oncol 2005; 31: 134-140.
5. Britten A, Newey VR, Clarke R,. A computerized gamma probe simulator to train surgeons in the localization of sentinel nodes. Nucl Med Commun 2007; 28: 225-229.
6. NHS Cancer Screening Programmes/Royal College of Pathologists. Pathology Reporting of Breast Disease. NHSBSP publication no. 58; 2005. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58.html [accessed 30 December 2012].
7. Wilson EB,. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927; 22: 209-212.
8. Newcombe RG,. Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 2: asymptotic methods and evaluation. Stat Med 2006; 25: 559-573.
9. Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, et al,. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001; 233: 51-59.
10. McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, et al,.; University of Louisville Breast Cancer Study Group. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001; 234: 292-299.
11. Kuehn T, Vogl FD, Helms G, Pueckler SV, Schirrmeister H, Strueber R, et al,.; German multi-institutional trial. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 2004; 30: 252-259.
12. Cody HS III, Hill AD, Tran KN, Brennan MF, Borgen PI,. Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg 1999; 229: 723-726.
13. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS,. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 1999; 6: 553-561.
14. Lee AC, Keshtgar MR, Waddington WA, Ell PJ,. The role of dynamic imaging in sentinel lymph node biopsy in breast cancer. Eur J Cancer 2002; 38: 784-787.
15. Mansel RE, Goyal A, Newcombe RG,; ALMANAC Trialists Group. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 2004; 5: 279-284.
16. Goyal A, Newcombe RG, Mansel RE,. Clinical relevance of internal mammary node drainage in sentinel node biopsy for breast cancer. J Clin Oncol 2005; 23: 8S.
17. Goyal A, Newcombe RG, Chhabra A, Mansel RE,; ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 2006; 99: 203-208.
18. Hung WK, Chan CM, Ying M, Chong SF, Mak KL, Yip AW,. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg 2005; 92: 1494-1497.
19. Goyal A, Douglas-Jones AG, Newcombe RG, Mansel RE,. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 2005; 11: 188-194.
20. Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallowfield L, et al,.; ALMANAC Trialists Group. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 2005; 41: 238-243.
21. Krag DN, Ashikaga T, Harlow SP, Skelly JM, Julian TB, Brown AM, et al,. Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial. J Natl Cancer Inst 2009; 101: 1356-1362.